Tramadol Hydrochloride
Product Images NDC 76420-205

4 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 76420-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tramadol 1)

Structure (Tramadol 1)
Chemical structure of tramadol hydrochloride showing its molecular arrangement including aromatic, cyclohexane, and amine groups along with the hydrochloride salt component.*
FDA Label Image

Figure 1 (Tramadol 2)

Figure 1 (Tramadol 2)
A pharmacokinetic curve showing the concentration (ng/mL) of tramadol and its metabolite M1 in plasma over time (hours) following single and multiple doses. The graph includes separate lines for tramadol single dose and multiple dose, as well as M1 single dose and multiple dose, illustrating changes in concentration up to 48 hours.*
FDA Label Image

Figure 2 (Tramadol 3)

Figure 2 (Tramadol 3)
A line chart titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting,' showing the percent discontinuing over a 25-day period during double-blind treatment with tramadol hydrochloride dosed up to 200 mg/day over 10 days. The x-axis represents days in double-blind, and the y-axis shows percent discontinuing due to nausea or vomiting.*
FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\tramadol\20191109_cabccc8a-6f9f-414c-93f0-6dec331ed74b\tramadol-4.jpg (Tramadol 4)

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\tramadol\20191109_cabccc8a-6f9f-414c-93f0-6dec331ed74b\tramadol-4.jpg (Tramadol 4)
Labels for TraMADOL HCl Tablets, USP 50 mg, relabeled and packaged by Enovachem Pharmaceuticals, located in Torrance, CA. Each label shows different quantities: 100, 30, 60, and 90 tablets, with NDC codes 76420-205-10, 76420-205-30, 76420-205-60, and 76420-205-90 respectively. Distributed by Sun Pharmaceutical Industries, Inc., the labels include barcode and QR code elements along with drug status as controlled substance (CIV).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.